Contact
searchSearch
HMP Global

Respiratory Syncytial Virus Topic Center

Featured Article

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network

Newsfeed

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
PharmLaw
Louisiana Secures $45M Settlement With CVS, Caremark Over PBM Practices
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
Federal Court Preliminarily Approves $5.275M Settlement in PharMerica Data Breach Class Action
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network
News
Slate Run Pharmaceuticals Recalls Eptifibatide Injection Nationwide Over Carton Labeling Error
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
PharmLaw
Physician Sentenced in $145 Million Compound Cream Kickback Scheme Involving DOL-OWCP Billing
02/25/2026
Grace Taylor, MS, MA
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced...
02/25/2026
Pharmacy Learning Network
News
Thiamine HCl Sodium Chloride Injection Recalled for Lack of Sterility Assurance
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Oxycodone Hydrochloride
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
PharmLaw
Atlantic Biologicals Enters Deferred Prosecution Agreement in Opioid Distribution Scheme
02/18/2026
Hannah Musick
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation...
02/18/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use